Literature DB >> 12088935

Myocardial ischemia and cytokine response are associated with subsequent onset of infections after noncardiac surgery.

Claudia D Spies1, Hartmut Kern, Torsten Schröder, Michael Sander, Henning Sepold, Philip Lang, Karl Stangl, Steffen Behrens, Pranav Sinha, Walter Schaffartzik, Klaus-Dieter Wernecke, Wolfgang J Kox, Uday Jain.   

Abstract

UNLABELLED: Postoperative myocardial ischemia (POMI) is prevalent among patients after major noncardiac surgery. Surgery, as well as POMI, may modulate the immune system, potentially worsening patient outcome. We sought to investigate the modulation of soluble interleukin (IL)-6 and IL-10 by POMI and its association with increased postoperative infection rates. Two-hundred-three patients undergoing elective major abdominal, vascular, and orthopedic surgery participated in this prospective observational study. Perioperative management was standardized. Hemodynamic variables were kept within 20% of baseline. POMI was assessed by Holter electrocardiography starting at least 8 h before the induction of anesthesia and continued until 96 h after surgery. Twelve-lead electrocardiograms, cardiac enzymes, and immune variables were obtained at the time of admission to the hospital, before surgery, before the induction of anesthesia, after surgery, at the time of admission to the intensive care unit, and 6, 12, 18, 24, 36, 48, 72, 96, 120, 144, and 168 h after surgery. Infections were diagnosed according to the Centers for Disease Control criteria. The incidence of POMI was 27%, and the majority of cases (76%) occurred within the first 24 h after surgery. IL-6 and IL-10 levels significantly increased during surgery but did not differ between the POMI and Non-POMI groups. However, in the subset of patients who developed severe infections or sepsis (n = 47) a median of 3 days (range, 1-8 days) after surgery, the intraoperative increases of IL-6 and IL-10 in the POMI group were, respectively, 3 and 10 times higher compared with the increase in the Non-POMI group. By using a multifactorial analysis in these patients with severe infections, the type of surgical trauma was associated with an increased IL-6 response, whereas the increase in IL-10 was attributed to POMI. These findings suggest that immediate cytokine responses due to POMI and type of surgery might be relevant for the later onset of severe infections and sepsis. IMPLICATIONS: Postoperative myocardial ischemia (POMI) occurred in 27% of patients after major noncardiac surgery. This was associated with an immediate augmented cytokine response in the first 12 h after surgery in patients who developed severe infections or sepsis 3 days later. POMI was associated with an increased interleukin (IL)-10 response, whereas IL-6 was associated with the type of surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088935     DOI: 10.1097/00000539-200207000-00002

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  [Perioperative myocardial damage in non-cardiac surgery patients].

Authors:  J Roggenbach; B W Böttiger; P Teschendorf
Journal:  Anaesthesist       Date:  2009-07       Impact factor: 1.041

2.  Time course of endothelial damage in septic shock: prediction of outcome.

Authors:  Ortrud Vargas Hein; Klaudia Misterek; Jan-Peer Tessmann; Vera van Dossow; Michael Krimphove; Claudia Spies
Journal:  Crit Care       Date:  2005-05-13       Impact factor: 9.097

3.  Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients.

Authors:  Vera von Dossow; Koschka Rotard; Uwe Redlich; Ortrud Vargas Hein; Claudia D Spies
Journal:  Crit Care       Date:  2005-10-12       Impact factor: 9.097

4.  Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.

Authors:  Claudia Spies; Alawi Luetz; Gunnar Lachmann; Markus Renius; Clarissa von Haefen; Klaus-Dieter Wernecke; Marcus Bahra; Alexander Schiemann; Marco Paupers; Christian Meisel
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.